13 Neurotransmitter Clearance

After neurotransmitters have been released into the synaptic cleft, they act upon postsynaptic receptors, as covered in the previous chapters. That action must be terminated in order for proper neuronal communication to continue. This is accomplished mainly through two processes: neurotransmitter transport and/or degradation. Transport physically removes the neurotransmitter molecule from the synaptic cleft. Degradation breaks down the neurotransmitter molecule by enzyme activity.


Neurotransmitters can be degraded by enzymes in the synapse


Acetylcholine

Acetylcholine action is terminated by acetylcholinesterase, an enzyme present in the synaptic cleft. Acetylcholinesterase degrades acetylcholine into choline and acetate molecules. Choline is then transported back into the presynaptic terminal and used in the synthesis of new acetylcholine.

A diagram showing acetylcholine clearance where acetylcholinesterase enzyme in the synaptic cleft degrades acetylcholine into choline and acetate, with choline being transported back into the presynaptic terminal for reuse in acetylcholine synthesis. Link to detailed alternative text in caption.
Figure 13.1. Acetylcholine termination. Acetylcholinesterase in the synaptic cleft degrades acetylcholine into choline and acetate. Choline is transported back into the presynaptic terminal via a choline transporter for reuse in acetylcholine synthesis. This represents the only neurotransmitter cleared primarily through synaptic cleft degradation. ‘Acetylcholine Termination’ by Casey L. Henley (CC-BY-NC-SA). View detailed alternative text.

Neurotransmitters can be transported into glial cells and degraded by enzymes


Glutamate

Glutamate action is terminated by two mechanisms. Reuptake of glutamate molecules into the presynaptic terminal can occur, or glutamate can be transported into nearby glial cells. The excitatory amino acid transporters are sodium co-transporters and use the sodium electrochemical gradient to drive neurotransmitter transport. Within glial cells, glutamate is converted into glutamine by glutamine synthetase. Glutamine is then transported out of the glial cell and back into the presynaptic terminal for use in future glutamate synthesis. If glutamate is transported back into the presynaptic terminal, it can be repackaged in synaptic vesicles.

A diagram showing glutamate clearance through sodium-dependent transporters that move glutamate into either the presynaptic terminal (for repackaging) or glial cells (where glutamine synthetase converts it to glutamine for recycling back to neurons). Link to detailed alternative text in caption.
Figure 13.2. Glutamate termination. Excitatory amino acid transporters use sodium co-transport to move glutamate from the cleft into either the presynaptic terminal (where it is repackaged into vesicles) or glial cells (where glutamine synthetase converts it to glutamine). Glutamine is transported back to neurons for reconversion to glutamate, establishing the glutamate-glutamine cycle. ‘Glutamate Termination’ by Casey L. Henley (CC-BY-NC-SA). View detailed alternative text.

GABA and Glycine

Like glutamate, GABA and glycine action are terminated by either reuptake into the presynaptic terminal and packaging in synaptic vesicles or through transport into glial cells where breakdown can occur. The GABA and glycine transporter also use the sodium electrochemical gradient to drive the movement of the transmitter across the membrane.

A two-panel diagram showing that GABA and glycine use similar clearance mechanisms through sodium-dependent transporters that move these inhibitory neurotransmitters into either presynaptic terminals (for repackaging) or glial cells (for enzymatic breakdown). Link to detailed alternative text in caption.
Figure 13.3. GABA and glycine termination. Both inhibitory amino acid neurotransmitters are cleared through sodium-dependent transporters that move them into either the presynaptic terminal (for repackaging into vesicles) or glial cells (for enzymatic degradation). This shared clearance mechanism reflects their similar chemical properties as amino acids. ‘GABA and Glycine Termination’ by Casey L. Henley (CC-BY-NC-SA). View detailed alternative text.

Neurotransmitters can be transported back into the terminal and either degraded or repackaged


Dopamine

Dopamine action is terminated by reuptake into the presynaptic terminal via the dopamine transporter (DAT). Once inside the cell, dopamine is either degraded via the actions of either monoamine oxidase (MAO) or catechol-O-methyltransferase (COMT), or it is repackaged into vesicles.

A diagram showing dopamine termination through the dopamine transporter (DAT) that moves dopamine from the synaptic cleft back into the presynaptic terminal, where it is either degraded by MAO and COMT enzymes or repackaged into vesicles. Link to detailed alternative text in caption.
Figure 13.4. Dopamine termination. The dopamine transporter (DAT) moves dopamine from the synaptic cleft back into the presynaptic terminal. Once inside, dopamine is either degraded by monoamine oxidase (MAO) or catechol-O-methyltransferase (COMT), or repackaged into vesicles for reuse. Drugs like cocaine block DAT, prolonging dopamine action. ‘Dopamine Termination’ by Casey L. Henley (CC-BY-NC-SA). View detailed alternative text.

Norepinephrine

Norepinephrine follows the same pathway as dopamine. Reuptake into the presynaptic terminal occurs via the norepinephrine transporter (NET), and then the transmitter is either degraded within the cell by MAO or COMT or repackaged into synaptic vesicles.

A diagram showing norepinephrine termination through the norepinephrine transporter (NET) that returns norepinephrine to the presynaptic terminal, where it is either degraded by MAO and COMT or repackaged into vesicles, identical to dopamine clearance. Link to detailed alternative text in caption.
Figure 13.5. Norepinephrine termination. The norepinephrine transporter (NET) moves norepinephrine back into the presynaptic terminal, where it is either degraded by MAO or COMT, or repackaged into vesicles. This mechanism parallels dopamine clearance, as both are catecholamines sharing similar chemical structures and metabolic pathways. ‘Norepinephrine Termination’ by Casey L. Henley (CC-BY-NC-SA). View detailed alternative text.

Serotonin

Like the other monoamines, serotonin is transported back into the presynaptic terminal via the serotonin transporter (SERT). The difference between serotonin and the catecholamines dopamine and norepinephrine is that monoamine oxidase is the only enzyme used for degradation.

A diagram showing serotonin termination through the serotonin transporter (SERT) that returns serotonin to the presynaptic terminal, where it is either degraded by MAO (but not COMT) or repackaged, differing from catecholamines that use both enzymes. Link to detailed alternative text in caption.
Figure 13.6. Serotonin termination. The serotonin transporter (SERT) moves serotonin back into the presynaptic terminal, where it is either degraded by MAO (but not COMT) or repackaged into vesicles. Unlike catecholamines, serotonin’s indole structure makes it a substrate only for MAO. SSRIs block SERT, increasing synaptic serotonin availability. ‘Serotonin Termination’ by Casey L. Henley (CC-BY-NC-SA). View detailed alternative text.

Conclusion

Effective neurotransmitter termination ensures precise and regulated neural communication. By recycling or breaking down neurotransmitters, the synapse is prepared for subsequent signaling, maintaining the dynamic balance critical for nervous system function.

Key Takeaways

  • Neurotransmitter action in the synapse must be terminated
  • This occurs by either
    • reuptake into the presynaptic terminal where enzymatic degradation or repackaging into vesicles occurs
    • transport into glial cells where enzymatic degradation occurs
    • enzymatic degradation in the synapse

Test Yourself!

Try the quiz more than once to get different questions!

Video Lecture

definition

License

Icon for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

Foundations of Neuroscience Copyright © 2021 by Casey Henley is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, except where otherwise noted.